🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Modified Rankin Scale at 90 Days Versus National Institutes of Health Stroke Scale at 24 Hours as Primary Outcome in Acute Stroke Trials | Journal of the American Heart Association ahajournals.org/doi/10.1161/JA…

🤔❓Should we switch to tenecteplase for all ischemic strokes? Evidence and logistics Leading Opinion by Keith Muir Read here👇 journals.sagepub.com/doi/full/10.11…

🚀BREAKING news! The first trial site for SIFT has opened at Oslounivsykehus ! Hopefully launching at more hospitals in Norway soon. Thanks for good collaboration and hard work from the study team so far 💊🚦🧠Neurology Research - Oslo University Hospital

First patient included in the SIFT💊💉🩸🔬 🎉 Huge team effort and milestone 🤩

Sleep duration after stroke predicts post-stroke cognitive impairment - check it out! Impact of Insufficient or Excessive Sleep Duration on Cognitive Function After Stroke:Journal of the American Heart Association ahajournals.org/doi/full/10.11…

The 2nd pasient included in SIFT💊💉🩸🔬 ! Thanks to Vojtech Novotny and the rest of the team at Oslounivsykehus Always working for better patient outcomes and evolving the field of #stroke 🙏🐣

Comparing Early National Institutes of Health Stroke Scale Versus 90‐Day Modified Rankin Scale Outcomes in Acute Ischemic Stroke Trials: A Systematic Review and Analysis | Journal of the American Heart Association ahajournals.org/doi/10.1161/JA…

🚀BREAKING news! New trial site for SIFT has opened at @UNN Tromsø! Looking forward to our collaboration!

🚀Great news! New trial site for SIFT has opened at Vestre Viken #Bærum! Håkon Ihle-Hansen Looking forward to our collaboration! 🤩

🚀New trial site for SIFT has opened at Helse MøreogRomsdal Ålesund sykehus! 🙏🤩

🚀New trial site for SIFT has opened at Sykehuset Østfold Kalnes🙏🤩 Great to have you on board🧠💊

🚀New trial site for SIFT has opened at #Sørlandetsykehus Kristiansand! 🙏🤩 Nice to have you on board Arnstein Tveiten and team 🧠💊

🚀Great news! New trial site for SIFT has opened at Sykehuset i Vestfold Tønsberg. Looking forward to our collaboration Enida D. Bratli and Håvard Lisether🤩💊🧠

🚀Great week for the SIFT trial! New trial site opened at St. Olavs hospital 🤩Impressive study team 🙌 Fredrik Ildstad!

First patient included at Sykehuset i Vestfold Tønsberg Enida D. Bratli and Håvard Lisether🤩💊🧠 Congrats, great work🙏

🚀Great news! New trial site for SIFT has opened at Stavanger universitetssykehus. Looking forward to our collaboration Soffien Chadli Ajmi 🤩💊🧠

Great news☀️! First patient included at @UNN Tromsø. Congratulations Agnethe Eltoft and team🙏

Most viewed this week from JAMA Neurology: APOE epsilon ε4 is a significant risk factor for intracranial hemorrhage in patients with atrial fibrillation on apixaban. ja.ma/3TJHNb8

Soon we will ALL be giving IV TNK to stroke patients on DOACS. The drumbeats are pounding. Here is yet another comparative effectiveness study showing lower ICH and better mRS outcomes among DOAC pts given lytics compared to those who did not. ahajournals.org/doi/abs/10.116…

#STROKE: In a multicenter target trial analysis of patients with recent DOAC intake, IVT was linked to better outcomes and no excess bleeding vs. no IVT group. More trial data is needed.💉 #AHAJournals ahajournals.org/doi/full/10.11…